⌘K

Login Start Free

Home/Filings/4/0001209191-23-017704

4//SEC Filing

Glenning Robert 4

Accession 0001209191-23-017704

CIK 0000827871other

View on SEC.gov Company Profile

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 9:02 PM ET

Size

5.4 KB

Accession

0001209191-23-017704

Insider Transaction Report

Form 4

Period: 2023-03-07

EAGLE PHARMACEUTICALS, INC.EGRX

Glenning Robert

Director

Transactions

Award
Stock Option (right to buy)
2023-03-07+16,253→ 16,253 total
Exercise: $26.00Exp: 2033-03-07→ Common Stock (16,253 underlying)

Footnotes (1)

[F1]The option fully vests on March 7, 2024, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeother

Related Parties

1

filerCIK 0001678676

Filing Metadata

Form type: 4
Filed: Mar 8, 7:00 PM ET
Accepted: Mar 9, 9:02 PM ET
Size: 5.4 KB

View on SEC.gov